<?xml version="1.0"?><collection name="D0824-A"><document name="NYT_ENG_20050316.0289"><line>Giordano and colleagues studied the records of more than 27,000 women treated for breast cancer from 1973 to 1989 -- 13,998 with cancer in the left breast (near the heart) and 13,285 with cancer in the right breast.<annotation scu-count="0" sum-count="5" sums="21,22,32,37,6"/></line></document><document name="APW_ENG_20041018.0263"><line>&quot;Genes are important, but they don't explain it all,&quot; said Sandler, chief of the epidemiology branch at the environmental health institute.</line></document><document name="LTW_ENG_20041208.0094"><line>Winer chaired a panel for the American Society of Clinical Oncology that last month recommended that aromatase inhibitors become part of the standard arsenal of drugs used to treat breast cancer, but that the exact strategy of how to use them remains unclear.</line></document><document name="NYT_ENG_20050316.0289"><line>But Giordano cautioned that long-term follow-up is needed because the effects of radiation near the heart may not show up until 15 years after treatment.</line></document><document name="LTW_ENG_20041208.0094"><line>Some patients might still first try the older drug, tamoxifen, they said.</line></document><document name="NYT_ENG_20050215.0034"><line>The thyroid is a butterfly-shaped gland in the front of the neck that produces a variety of hormones regulating body metabolism.</line></document><document name="AFP_ENG_20050217.0195"><line>Dutch doctors believe that the new diagnostic can help pinpoint those women who are genetically more at risk of a recurrence than others, and this could spare low-risk patients from having to undergo unnecessary follow-up treatment.</line></document><document name="NYT_ENG_20050316.0289"><line>But studies in the '60s and '70s showed radiation for breast cancer also exposed the heart in women with left-sided tumors and increased their risk of heart attack and dying from heart disease.<annotation scu-count="0" sum-count="1" sums="13"/></line></document><document name="AFP_ENG_20050217.0195"><line>Such medication is routinely recommended as a precaution to prevent any recurrence of the cancer.</line></document><document name="APW_ENG_20041019.0402"><line>Because most breast cancer starts in a milk duct, scientists had theorized that flushing those ducts with fluid might draw out cancerous cells even before they could be spotted on a mammogram.</line><line>The &quot;meticulously performed&quot; research supports an earlier, smaller study that found similar failures, noted Dr. Carol Fabian of the Kansas Medical Center in Kansas City, in an accompanying editorial.</line></document><document name="LTW_ENG_20041208.0094"><line>&quot;We think women should start right away with an aromatase inhibitor,&quot; said Anthony Howell of the Christie Hospital in Manchester, England, who presented the findings at a meeting in San Antonio, Texas.</line></document><document name="AFP_ENG_20050217.0195"><line>At the moment, there is no global agreement as to what should be the common set of genes that should be incorporated in a standard test.</line></document><document name="NYT_ENG_20050215.0034"><line>The study spotlights the role that hormones besides estrogen play in development and progression of the hormone-sensitive cancer, said Dr. Massimo Cristofanilli, an associate professor of breast oncology and the lead author of the study.</line></document><document name="APW_ENG_20041019.0402"><line>But other studies of ductal lavage are continuing, to see if the technique can be used to help evaluate women's risk of breast cancer.</line></document><document name="AFP_ENG_20050217.0195"><line>The team then tested the &quot;signature&quot; on the genetic profile of 171 other cancer patients who had had initial treatment for their tumour and whose health had been carefully monitored over the next five years to see if the cancer had returned.</line></document><document name="NYT_ENG_20050215.0034"><line>Women with underactive thyroid glands had a 61 percent lower risk of having invasive breast cancer, or aggressive cancer that had spread into surrounding breast tissue or lymph nodes.<annotation scu-count="1" sum-count="1" sums="48"><scu uid="10" label="Hypothyroidism apparently lessens chances of developing aggressive forms" weight="2"/></annotation></line></document><document name="XIN_ENG_20050323.0139"><line>The study suggested young women who carried inherited variations of the BRCA1 or BRCA2 genes should not be discouraged from using oral contraceptives.</line></document><document name="LTW_ENG_20041208.0094"><line>&quot;I would say that these results generally provide confirmation of what was previously seen in this trial but are not strikingly different,&quot; said Eric Winer of the Dana-Farber Cancer Institute in Boston.</line></document><document name="XIN_ENG_20050323.0139"><line>The study was conducted by researchers from University of Melbourne on some 2,000 women under the age of 40, including 1,156 breast cancer patients in Australia, Canada and the United States.<annotation scu-count="0" sum-count="3" sums="0,30,43"/></line></document><document name="APW_ENG_20041018.0263"><line>The sisters who volunteer will donate blood, urine, toenails _ even household dust _ to help uncover how daily rituals and routines, as well as genetics, factor into breast cancer risk.</line><line>Women who inherit an altered version of either gene have a higher risk of getting breast or ovarian cancer.<annotation scu-count="0" sum-count="1" sums="20"/></line></document><document name="AFP_ENG_20050109.0553"><line>Menendez worked with Ruth Lupu, director of the Evanston Northwestern Health Research Institute's Breast Cancer Translational Program and Ramon Colomer, head of the Medical Oncology Division at Institut Catala d' Oncologia in Girona, Spain.<annotation scu-count="0" sum-count="2" sums="38,44"/></line></document><document name="LTW_ENG_20041208.0094"><line>They do not, however, reduce the risk of osteoporosis, as tamoxifen does.</line></document><document name="NYT_ENG_20050215.0034"><line>An underactive thyroid gland -- a condition afflicting as many as 20 percent of older women -- also apparently lessens a woman's chances of developing an aggressive form of breast cancer, according to a study that provides new evidence for a long-debated link.<annotation scu-count="1" sum-count="1" sums="36"><scu uid="10" label="Hypothyroidism apparently lessens chances of developing aggressive forms" weight="2"/></annotation></line><line>The cause is unknown, although some evidence points to an immune system malfunction, Cristofanilli noted.</line></document><document name="CNA_ENG_20041013.0013"><line>Compared with hormonal drugs, SR-16158 is less likely to trigger cardiovascular disease in patients, Whang-Peng said.</line></document><document name="APW_ENG_20041018.0263"><line>The Sister Study, conducted by the National Institute of Environmental Health Sciences, part of the government's National Institutes of Health, is the largest study of its kind.</line></document><document name="XIN_ENG_20050118.0004"><line>To evaluate whether weakened DNA repair capacity in the nucleotide excision pathway that fixes DNA alterations known as bulky DNA adducts is associated with breast cancer risk, Santella and colleagues analyzed cell lines generated from blood samples from pairs of sisters, in which one had been diagnosed with breast cancer but the other had not.</line></document><document name="NYT_ENG_20050316.0289"><line>Local researchers have found that radiation therapy likely no longer leaves breast cancer patients at an increased risk of potentially deadly heart disease.<annotation scu-count="1" sum-count="9" sums="11,12,14,23,30,42,44,49,51"><scu uid="6" label="Advances in technology make radiation safer" weight="3"/></annotation></line></document><document name="CNA_ENG_20041013.0013"><line>The National Health Research Institutes (NHRI) Wednesday established a strategic alliance with U.S.-based Bridge Pharmaceuticals on the research and development of cancer medicines.<annotation scu-count="0" sum-count="1" sums="51"/></line></document><document name="XIN_ENG_20050323.0139"><line>&quot;There's no strong guidelines but, in general, women are being advised cautiously not to use oral contraceptives if they are carriers... but that's not necessarily found in evidence,&quot; he said.</line></document><document name="AFP_ENG_20050217.0195"><line>The treatment usually entails follow-up care in the form of chemotherapy -- powerful drugs that act on tumours -- or hormone treatment.</line></document><document name="XIN_ENG_20050118.0004"><line>Earlier studies have suggested that deficiency in cells' capacity for DNA repair contributes to the accumulation of DNA damage and accelerates the genetic changes leading to cancer.</line></document><document name="LTW_ENG_20041208.0094"><line>The researchers had previously reported data from three years of study that showed Arimidex prevented more recurrences than tamoxifen.</line></document><document name="CNA_ENG_20041013.0013"><line>The two medicines have been tested on animals in the United States and have been shown to be effective in inhibiting the growth of cancer cells, the officials said.<annotation scu-count="0" sum-count="2" sums="29,55"/></line></document><document name="NYT_ENG_20050215.0034"><line>Since then, smaller studies on women with several thyroid conditions have generated conflicting results.</line></document><document name="LTW_ENG_20041208.0094"><line>&quot;But the exact timing of how one should use them remains unclear.&quot;</line><line>Other research presented at the meeting found that switching to Arimidex or another aromatase inhibitor, called Aromasin, was more effective than staying on tamoxifen for five years.</line><line>But tamoxifen can be taken only for five years and increases the risk of uterine cancer and blood clots that can cause strokes.<annotation scu-count="0" sum-count="1" sums="29"/></line></document><document name="CNA_ENG_20041013.0013"><line>The SR-13668 is for oral consumption and can curb the AKT retroviral oncogene protein, which is extremely active in patients with malignant tumors, including breast cancer, lung cancer, prostate cancer, liver cancer, ovary cancer and colon cancer, according to the NHRI.<annotation scu-count="1" sum-count="2" sums="21,5"><scu uid="1" label="New drug SR-13668 curbs oncogene proteins in cancer patients" weight="3"/></annotation></line></document><document name="LTW_ENG_20041208.0094"><line>A new type of drug shows growing promise as a more potent way for many breast cancer patients to significantly cut their risk of a recurrence, researchers reported Wednesday.<annotation scu-count="0" sum-count="3" sums="23,30,41"/></line></document><document name="XIN_ENG_20050118.0004"><line>They found that DNA repair capacity was lower in breast cancer patients than in the control subjects.<annotation scu-count="1" sum-count="3" sums="13,19,48"><scu uid="11" label="DNA repair deficiency strongly associates with susceptibility to breast cancer" weight="3"/></annotation></line></document><document name="NYT_ENG_20050316.0289"><line>It was 10.2 percent for those with right-breast cancer.</line></document><document name="AFP_ENG_20050109.0553"><line>&quot;Our findings underpin epidemiological studies that show that the Mediterranean diet has significant protective effects against cancer, heart disease and ageing,&quot; said the study's lead author Javier Menendez, of Northwestern University's Feinberg medical school in Chicago.<annotation scu-count="0" sum-count="1" sums="33"/></line></document><document name="AFP_ENG_20050217.0195"><line>Only about a third of all patients actually need the follow-up therapy, however, which can be aggressive with big side-effects.</line></document><document name="NYT_ENG_20050215.0034"><line>Cristofanilli noted that the women with underactive thyroid glands all were taking thyroid hormone replacements, which suggests it is not the thyroid hormone level itself that influences the growth of breast cancer.<annotation scu-count="1" sum-count="1" sums="57"><scu uid="14" label="Other studies are looking into the effects and effectiveness of an underactive thyroid" weight="1"/></annotation></line></document><document name="LTW_ENG_20041208.0094"><line>The new data found the benefits continued after five years and appeared to be even greater, the researchers said.</line></document><document name="XIN_ENG_20050323.0139"><line>The study found those with an inherited mutation in the BRCA1 gene, a known risk factor for early onset breast cancer, were about four times less likely to develop the disease if they were taking oral contraceptives.<annotation scu-count="1" sum-count="1" sums="0"><scu uid="9" label="Researchers study the effectiveness of oral contraceptives" weight="4"/></annotation></line></document><document name="XIN_ENG_20050118.0004"><line>A latest study led by Regina Santella at the Columbia University School of Public Health is due to published in the Jan. 19 issue of the Journal of the National Cancer Institute.<annotation scu-count="0" sum-count="1" sums="18"/></line></document><document name="AFP_ENG_20050217.0195"><line>If diagnosed in time, up to 70 percent of women who are given surgery or radiotherapy for this disease are cured.<annotation scu-count="0" sum-count="1" sums="43"/></line></document><document name="NYT_ENG_20050215.0034"><line>&quot;This is good news, because it indicates that the condition that brings out hypothyroidism is protective enough that it either delays or creates the possibility of developing a less aggressive form of the disease,&quot; he said.</line></document><document name="LTW_ENG_20041208.0094"><line>The results were so strong that researchers recommended that most postmenopausal women struck by breast cancer should immediately begin taking an aromatase inhibitor as soon as they complete the standard regimen of surgery, radiation and, often, chemotherapy, instead first going on an older drug.</line></document><document name="XIN_ENG_20050118.0004"><line>&quot;When DNA repair capacity can be measured easily and quickly, the scientific community will be able to clearly understand the role of DNA repair capacity in the development of cancer and possibly to develop interventions to reduce cancer incidence and mortality,&quot; they wrote in an editorial in the journal.</line></document><document name="APW_ENG_20041019.0402"><line>Doctors put an anesthetic on the nipple and inserted a threadlike catheter to flush milk ducts with fluid that dislodges and draws out cells.</line></document><document name="AFP_ENG_20050217.0195"><line>The study is led by John Foekens of the Erasmus Medical Centre in Rotterdam.</line></document><document name="XIN_ENG_20050118.0004"><line>Deficient DNA repair capacity was associated with a twofold increase in the risk of breast cancer.<annotation scu-count="1" sum-count="1" sums="57"><scu uid="11" label="DNA repair deficiency strongly associates with susceptibility to breast cancer" weight="3"/></annotation></line></document><document name="NYT_ENG_20050316.0289"><line>Following surgery, close to 50 percent of women with breast cancer undergo radiation, which can cut the odds of cancer returning by two-thirds.</line></document><document name="NYT_ENG_20050215.0034"><line>Hypothyroidism occurs when production of these vital hormones slows down.</line></document><document name="NYT_ENG_20050316.0289"><line>The heart disease death rate of both groups diagnosed during the decade was about 5.5 percent.</line><line>In the past, she said, it really was &quot;one size fits all.&quot;</line></document><document name="LTW_ENG_20041208.0094"><line>But it's been unclear whether women should take tamoxifen first and then switch to an aromatase inhibitor, or simply take an aromatase inhibitor from the start.</line></document><document name="XIN_ENG_20050323.0139"><line>&quot;They definitely have the power to make life decisions about the use of oral contraceptives not worrying overly about the effect it may have on their breast cancer risks,&quot; he said.</line></document><document name="AFP_ENG_20050217.0195"><line>This is why doctors recommend regular mammary screenings and why they are so keen on getting a tool to help identify women who could be genetically at risk.</line></document><document name="NYT_ENG_20050215.0034"><line>The results could help researchers develop new medications for treatment and prevention of breast cancer, he said.</line></document><document name="NYT_ENG_20050316.0289"><line>It continued to be used because the benefit was greater than the risk.</line></document><document name="APW_ENG_20041019.0402"><line>The milk duct technique, called ductal lavage, is among those experimental alternatives.<annotation scu-count="3" sum-count="3" sums="19,48,57"><scu uid="13" label="Ductal lavage proved unreliable for detecting early cancer" weight="1"/><scu uid="19" label="Other studies are looking into the effects and effectiveness flushing of milk ducts" weight="1"/><scu uid="19" label="Other studies are looking into the effects and effectiveness flushing of milk ducts" weight="1"/></annotation></line></document><document name="AFP_ENG_20050109.0553"><line>Her-2/neu is one of the most important oncogenes in breast cancer,&quot; said Menendez.</line></document><document name="NYT_ENG_20050215.0034"><line>&quot;Thyroid appears to be one of them.&quot;</line></document><document name="APW_ENG_20041018.0263"><line>Breast cancer is the second most commonly diagnosed cancer in women, after skin cancer.<annotation scu-count="0" sum-count="4" sums="32,49,5,6"/></line></document><document name="NYT_ENG_20050316.0289"><line>&quot;This is great news that should allow women to choose to have radiation without fear it could cause heart disease.&quot;<annotation scu-count="0" sum-count="1" sums="55"/></line></document><document name="APW_ENG_20041019.0402"><line>Analyzing cells from milk ducts doesn't reliably detect breast cancer, U.S. researchers reported Tuesday _ dashing hopes that the experimental technique could diagnose high-risk women sooner.<annotation scu-count="1" sum-count="5" sums="12,25,41,42,51"><scu uid="19" label="Other studies are looking into the effects and effectiveness flushing of milk ducts" weight="1"/></annotation></line></document><document name="AFP_ENG_20050109.0553"><line>Oleic acid suppressed the gene, and other tests showed that it boosted an antibody treatment trastuzumab (Herceptin), which targets the gene and has helped to prolong the lives of many breast cancer patients, the researchers said.</line></document><document name="APW_ENG_20041018.0263"><line>&quot;The truth is that only half of breast cancer cases can be attributed to known factors.&quot;</line></document><document name="AFP_ENG_20050217.0195"><line>They found the &quot;signature&quot; was 93-percent accurate in predicting those who had had a recurrence within five years, although it was much less precise (48-percent accurate) in predicting patients whose disease did not return in that time.</line></document><document name="CNA_ENG_20041013.0013"><line>The SR-16158, meanwhile, is intended for the treatment of breast cancer.<annotation scu-count="1" sum-count="2" sums="18,32"><scu uid="3" label="New drug SR-16158 treats breast cancer" weight="3"/></annotation></line></document><document name="AFP_ENG_20050109.0553"><line>&quot;To our knowledge this is the first report that a dietary monounsaturated fatty acid previously suggested to be protective against breast cancer significantly down-regulates the expression of Her-2/neu, cutting it by up to 46 percent.<annotation scu-count="1" sum-count="1" sums="29"><scu uid="20" label="Oleic acid dramatically cuts expression of breast cancer precursor gene Her-2/neu and amplifies Herceptin" weight="1"/></annotation></line></document><document name="AFP_ENG_20050217.0195"><line>The problem though is that the proposed &quot;signatures&quot; either overlap or are different.</line></document><document name="LTW_ENG_20041208.0094"><line>The new findings are from a study involving 9,366 postmenopausal women with early, estrogen-sensitive breast cancer who took either tamoxifen or an aromatase inhibitor called Arimidex (known generically as anastrozole).</line></document><document name="NYT_ENG_20050316.0289"><line>It has not been that long for some of the patients in the study.</line></document><document name="NYT_ENG_20050215.0034"><line>Scientists long have been intrigued by the role of the thyroid gland in breast disease.<annotation scu-count="1" sum-count="1" sums="19"><scu uid="14" label="Other studies are looking into the effects and effectiveness of an underactive thyroid" weight="1"/></annotation></line></document><document name="LTW_ENG_20041208.0094"><line>&quot;This is a very large study and it confirms there is a benefit and that aromatase inhibitors should become part of standard therapy,&quot; said JoAnne Zujewski of the National Cancer Institute.</line><line>Before the development of aromatase inhibitors, women whose breast cancers were promoted by the hormone estrogen -- which is true of most -- were given tamoxifen to reduce their risk of recurrence.<annotation scu-count="1" sum-count="4" sums="19,37,43,48"><scu uid="2" label="Another promising new drug is aromatose inhibitor" weight="3"/></annotation></line></document><document name="CNA_ENG_20041013.0013"><line>The first phase of clinical trials on humans is expected to start next year in Taiwan, they said.</line></document><document name="NYT_ENG_20050215.0034"><line>Scientists compared 1,036 women who had been treated for breast cancer to 1,088 healthy women who had attended the hospital's screening clinics.</line></document><document name="NYT_ENG_20050316.0289"><line>A study by researchers at the University of Texas M.D. Anderson Cancer Center shows the risk, significant in the 1960s and 1970s, has steadily declined over the past 25 years until it is now probably gone.</line></document><document name="LTW_ENG_20041208.0094"><line>The new study was funded by AstraZeneca, which makes the drug, but Howell said the researchers had complete independence.</line></document><document name="NYT_ENG_20050215.0034"><line>Thyroid hormones affect growth, fertility and the body's use of nutrients and oxygen.</line></document><document name="AFP_ENG_20050109.0553"><line>&quot;Additionally, alongside the sensitizing effect of oleic acid on the efficacy of Herceptin we found it increased the expression of a protein (p27Kip1), a tumor suppresser protein, which is implicated in the development of resistance to Herceptin treatment.&quot;</line></document><document name="NYT_ENG_20050215.0034"><line>(Cindy Tumiel can be reached at ctumiel@express-news.net)</line></document><document name="XIN_ENG_20050323.0139"><line>&quot;We don't believe that you can say oral contraceptive use is going to be the magic elixir yet but we do say that the use of oral contraceptives should not be contraindicated (in women with a high genetic breast cancer risk),&quot; Hopper said.</line></document><document name="XIN_ENG_20050118.0004"><line>&quot;These data support the hypothesis that deficient DNA repair capacity is associated with susceptibility to breast cancer and may be a valuable in vitro biomarker to identify high-risk subjects, especially in familial breast cancer families,&quot; researchers wrote in their paper.</line></document><document name="LTW_ENG_20041208.0094"><line>&quot;We still should be careful not to rush to judgment as to what the best way should be to use these drugs,&quot; Winer said.</line></document><document name="APW_ENG_20041019.0402"><line>To test it, doctors at Chicago's Northwestern Memorial Hospital administered ductal lavage to 39 women just before their breasts were removed for known cancer.</line></document><document name="NYT_ENG_20050215.0034"><line>The study was published Monday in the online journal Cancer, a publication of the American Cancer Society.<annotation scu-count="0" sum-count="1" sums="5"/></line></document><document name="LTW_ENG_20041208.0094"><line>&quot;This data strengthens the thinking that tamoxifen is tending to die out as a treatment and is being replaced by these aromatase inhibitors,&quot; Howell said.</line><line>Aromatase inhibitors block the formation of estrogen in the first place and carry none of those risks.</line></document><document name="NYT_ENG_20050316.0289"><line>Giordano said the team has such follow-up plans.</line></document><document name="XIN_ENG_20050323.0139"><line>The findings go against the researchers' original hypothesis that the pill would increase breast cancer in high risk groups.<annotation scu-count="0" sum-count="1" sums="13"/></line></document><document name="NYT_ENG_20050316.0289"><line>The study was published in Wednesday's Journal of the National Cancer Institute.<annotation scu-count="0" sum-count="2" sums="13,14"/></line></document><document name="APW_ENG_20041019.0402"><line>Ductal lavage signaled cancer in only a fraction of these women, lead researcher Dr. Seema Khan reported Tuesday in the Journal of the National Cancer Institute.</line></document><document name="APW_ENG_20041018.0263"><line>The disease will kill about 40,110 American women in 2004, according to the Centers for Disease Control and Prevention.</line></document><document name="CNA_ENG_20041013.0013"><line>Jacqueline Whang-Peng, director of the NHRI's Division of Cancer Research, said that compared with existing cancer medicines, the two drugs have produced better therapeutic results and less side effects.</line></document><document name="NYT_ENG_20050215.0034"><line>&quot;We have been focusing only on one hormone acting on the breast tissue, but there is a variety of other hormones that create the environment for the development of cancer,&quot; Cristofanilli said.</line></document><document name="AFP_ENG_20050217.0195"><line>Scientists in the Netherlands say they have developed a powerful diagnostic tool, based on a telltale gene &quot;signature,&quot; that could help breast-cancer patients avoid unnecessary follow-up treatment.<annotation scu-count="0" sum-count="1" sums="11"/></line></document><document name="APW_ENG_20041018.0263"><line>Women who have not been diagnosed with breast cancer are eligible if a sister, living or dead, has had breast cancer.<annotation scu-count="0" sum-count="1" sums="20"/></line></document><document name="APW_ENG_20041019.0402"><line>&quot;Ductal lavage should not be recommended to high-risk women as a technique to detect cancer earlier than imaging modalities&quot; she concluded.</line><line>&quot;Ductal lavage cannot be considered a sensitive screening tool,&quot; Fabian agreed.</line><line>Mammograms work very well at detecting early breast cancer, but they're not perfect.</line></document><document name="CNA_ENG_20041013.0013"><line>She said the two new medicines will be available on the market three years from now at the earliest if the clinical trials proceed smoothly.</line></document><document name="AFP_ENG_20050217.0195"><line>They found a &quot;signature&quot; of protein markers, expressed by 76 genes, which were frequently found among 115 stored tumours taken from patients who had lymph-node negative breast cancer.</line></document><document name="APW_ENG_20041019.0402"><line>And even when it did, Khan's research found the cells produced didn't always signal cancer.<annotation scu-count="0" sum-count="1" sums="32"/></line></document><document name="LTW_ENG_20041208.0094"><line>Other experts praised the findings as confirming that aromatase inhibitors should play an important role in treating breast cancer patients but said it remains unclear whether all eligible women should immediately begin an aromatase inhibitor.</line><line>The latest findings from a large international study also found that the drug, called an aromatase inhibitor, appears to sharply reduce the chances that many breast cancer patients will develop a new cancer in the other breast or have the cancer spread elsewhere.<annotation scu-count="1" sum-count="4" sums="22,3,35,49"><scu uid="2" label="Another promising new drug is aromatose inhibitor" weight="3"/></annotation></line></document><document name="AFP_ENG_20050109.0553"><line>Olive oil can help fight breast cancer, a discovery that researchers said in a study out Sunday could guide the development of related treatment.<annotation scu-count="1" sum-count="10" sums="10,11,14,23,25,30,33,36,40,6"><scu uid="8" label="Researchers study the effectiveness of olive oil" weight="3"/></annotation></line></document><document name="XIN_ENG_20050118.0004"><line>DNA repair is the system of defenses designed to protect the integrity of the genome.</line></document><document name="LTW_ENG_20041208.0094"><line>But other experts said the data simply confirmed the study's earlier findings and that the results of other ongoing studies were needed before changing the standard recommendations.</line></document><document name="NYT_ENG_20050316.0289"><line>&quot;To the best of our knowledge, radiation is safe for breast cancer patients,&quot; said Dr. Sharon Giordano, the study's lead author and a professor in M.D. Anderson's department of breast medical oncology.<annotation scu-count="1" sum-count="1" sums="43"><scu uid="6" label="Advances in technology make radiation safer" weight="3"/></annotation></line></document><document name="XIN_ENG_20050118.0004"><line>Other scientists remarked on the need for developing better laboratory tests for such studies.</line><line>In addition, when the data were stratified into quartiles of DNA repair capacity, the risk of breast cancer was three times higher among women with the poorest DNA repair capacity compared with those with the highest.</line></document><document name="APW_ENG_20041018.0263"><line>&quot;By studying sisters who share the same genes, often had similar experiences and environments, and are at twice the risk of developing breast cancer, we have a better chance of learning what causes this disease,&quot; Dr. Dale Sandler, the study's principal investigator, said in a statement Monday.<annotation scu-count="0" sum-count="1" sums="55"/></line></document><document name="NYT_ENG_20050215.0034"><line>More than a century ago, a doctor in Scotland fed thyroid hormone to women whose breast cancer had spread throughout their body.</line></document><document name="AFP_ENG_20050217.0195"><line>Several previous studies have also identified gene &quot;signatures&quot; to test for breast cancer, although this is the largest by far.</line></document><document name="NYT_ENG_20050316.0289"><line>Of the women who underwent surgery in the 1970s, the death rate for heart disease among those with tumors on the left side was 13.1 percent.</line></document><document name="APW_ENG_20041018.0263"><line>A new U.S. study will investigate genetic and environmental causes of breast cancer by enrolling 50,000 sisters of women already diagnosed with the disease.<annotation scu-count="1" sum-count="12" sums="10,12,14,19,20,25,37,41,42,48,5,6"><scu uid="4" label="NIH has undertaken a study of sisters to find genetic and environmental causes" weight="4"/></annotation></line></document><document name="NYT_ENG_20050316.0289"><line>Giordano attributed the improvement to advances in technology and techniques that enable therapists to individualize radiation treatment, better targeting each patient's tumor.</line></document><document name="XIN_ENG_20050118.0004"><line>Deficiencies in the ability of cells to repair damaged DNA are associated with an increased risk of breast cancer, researchers at Columbia University said Monday.<annotation scu-count="1" sum-count="3" sums="25,43,51"><scu uid="11" label="DNA repair deficiency strongly associates with susceptibility to breast cancer" weight="3"/></annotation></line></document><document name="APW_ENG_20041018.0263"><line>To be eligible for the study, women need to be between 35 and 74 years old.</line></document><document name="LTW_ENG_20041208.0094"><line>Tamoxifen blunts estrogen's effects.</line><line>Tamoxifen cut the recurrence risk by about 50 percent; Arimidex appeared to reduce recurrence by an extra 26 percent, the researchers said.</line></document><document name="CNA_ENG_20041013.0013"><line>The first cooperation project between the two sides will be the clinical development in Taiwan of two new cancer medicines, SR-13668 and SR-16158, NHRI officials said.<annotation scu-count="1" sum-count="2" sums="29,55"><scu uid="17" label="a Taiwanese-U.S. cooperative effort is developing a new breast-cancer drug" weight="1"/></annotation></line></document><document name="XIN_ENG_20050323.0139"><line>&quot;We really thought that oral contraceptives would be bad,&quot; John Hopper, director of the university's Center for Genetic Epidemiology, was quoted by Australian Associated Press as saying Wednesday.</line></document><document name="NYT_ENG_20050316.0289"><line>But during the 1980s, the risk declined by 6 percent annually in women with left-sided breast cancer compared with those with the disease on their right side, according to the study.<annotation scu-count="0" sum-count="1" sums="43"/></line></document><document name="APW_ENG_20041019.0402"><line>Among the problems: There are numerous milk ducts in the breast, and it's impossible to know in advance if ductal lavage produced cells from the one that contains cancer.</line></document><document name="NYT_ENG_20050316.0289"><line>Doctors have been telling patients for years that radiation is much safer than it used to be, but the study is the first to offer evidence to support the position.</line></document><document name="XIN_ENG_20050118.0004"><line>&quot;It is unclear at this time whether there are any interventions that could alter DNA repair capacity and what effect such interventions might have on risk,&quot; they said.</line></document><document name="APW_ENG_20041018.0263"><line>The women will be tracked for 10 years so researchers can study what links the few who get breast cancer compared with the majority who do not.<annotation scu-count="0" sum-count="2" sums="20,55"/></line></document><document name="AFP_ENG_20050217.0195"><line>Breast cancer, like ovarian cancer, is a &quot;silent killer&quot; of women.</line></document><document name="APW_ENG_20041019.0402"><line>They don't work as well on the more dense breast tissue of women under 50, so scientists are testing alternatives like MRI scans to screen younger women at high risk of cancer because a close relative had it.</line></document><document name="AFP_ENG_20050217.0195"><line>The research, reported in next Saturday's issue of the British medical weekly The Lancet, is focussed on a condition called lymph-node negative breast cancer.<annotation scu-count="0" sum-count="1" sums="44"/></line></document><document name="NYT_ENG_20050215.0034"><line>Symptoms can include dry skin, weight gain, sensitivity to cold, forgetfulness and fertility problems.</line></document><document name="AFP_ENG_20050109.0553"><line>Menendez said the findings should not only help in understanding the molecular mechanisms by which individual dietary fatty acids regulate the malignant behavior of breast cancer cells, but also suggested eating oleic acid may help Herceptin work in breast cancer patients with the Her-2/neu gene.<annotation scu-count="1" sum-count="4" sums="10,38,40,8"><scu uid="20" label="Oleic acid dramatically cuts expression of breast cancer precursor gene Her-2/neu and amplifies Herceptin" weight="1"/></annotation></line></document><document name="LTW_ENG_20041208.0094"><line>&quot;We think the benefit justifies offering this treatment as early as possible.&quot;</line></document><document name="APW_ENG_20041018.0263"><line>BRCA1 and BRCA2, however, are implicated in just 5 percent to 10 percent of breast cancer cases.</line></document><document name="AFP_ENG_20050109.0553"><line>Researchers showed in a series of laboratory experiments on breast cancer cells that oleic acid, found in olive oil, dramatically cuts the levels of a cancer-promoting gene called Her-2/neu (also known as erb B-2), according to Menendez.<annotation scu-count="2" sum-count="2" sums="33,40"><scu uid="8" label="Researchers study the effectiveness of olive oil" weight="3"/><scu uid="20" label="Oleic acid dramatically cuts expression of breast cancer precursor gene Her-2/neu and amplifies Herceptin" weight="1"/></annotation></line></document><document name="NYT_ENG_20050215.0034"><line>Doctors at the University of Texas M.D. Anderson Cancer Center found that women who were diagnosed with hypothyroidism were less likely to have breast cancer, and those who did were likely to have a less-aggressive form of the disease.<annotation scu-count="0" sum-count="1" sums="43"/></line></document><document name="XIN_ENG_20050323.0139"><line>An Australian research suggests that taking oral contraceptives reduces the risk of breast cancer carrying breast cancer genes.<annotation scu-count="1" sum-count="13" sums="0,11,13,21,22,23,32,37,41,44,49,57,6"><scu uid="9" label="Researchers study the effectiveness of oral contraceptives" weight="4"/></annotation></line></document><document name="APW_ENG_20041019.0402"><line>The test uncovered clear cancer signs in just 13 percent of the cancerous breasts tested, and possible signs in 42 percent.</line></document><document name="AFP_ENG_20050109.0553"><line>&quot;In our tests, oleic acid's inhibition of Her-2/neu synergistically interacted with Herceptin-based immunotherapy by promoting the death of breast cancer cells exhibiting high levels of the oncogene.</line></document><document name="NYT_ENG_20050215.0034"><line>He said doctors need to study whether the immune system response in these women is playing some role in slowing or preventing breast cancer.</line></document><document name="APW_ENG_20041018.0263"><line>Some 215,990 American women will be diagnosed with breast cancer this year, according to the American Cancer Society.</line></document><document name="AFP_ENG_20050109.0553"><line>High levels of the gene occur in over a fifth of breast cancer patients and are associated with highly aggressive tumors that have a poor prognosis, according to findings reported in the January 10 Annals of Oncology.</line></document><document name="APW_ENG_20041018.0263"><line>For instance, BRCA1 and BRCA2 are genes that normally limit cell growth.</line></document><document name="NYT_ENG_20050316.0289"><line>In an accompanying editorial, Dr. Jack Cuzick of London's Wolfson Institute of Preventive Medicine said follow-up is &quot;essential&quot; to obtain &quot;definitive evidence&quot; the risk has been completely eliminated.</line></document></collection>